| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |